Skip to content

Hologic up 7% on bullish Q4 outlook

September 11, 2020

Hologic (NASDAQ:HOLX) jumps 7% premarket on light volume in reaction to its upward revision of Q4 guidance driven by strong sales of COVID-19 tests and Panther instruments.

The company forecasts revenue of $1,225M – $1,275M, up 54 – 60% from a year ago and up from its outlook of $925M – 1.025M provided in July.

The increased revenue is also expected to drive non-GAAP EPS significantly above prior guidance of $0.95 – 1.15.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: